Development of analysing blood concentration of iv busulfan in patients by dried blood spot method
Not Applicable
- Conditions
- Acute myeloid leukemia, Chronic myeloid leukemia, Myelodysplastic syndrome, Acute lymphoblastic leukemia, Chronic lymphocytic leukemia, Malignant lymphoma
- Registration Number
- JPRN-UMIN000015034
- Lead Sponsor
- Department of Hematology, Toranomon Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
*History of drug hypersensitivity to the drugs used in the treatment *Dose of single injection is not 0.8 mg/kg for 2 hour infusion *Patients who is not appropriate for entering the study by attending physician
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparative analysis of pharmacokinetics of BU by HPLC and DBS methods
- Secondary Outcome Measures
Name Time Method